News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Foreign institutional investors withdrew a record $18.84 billion from Indian equities in just over three months, pressuring the Nifty.
  • Senior U.S. and Iranian delegations met in Islamabad, but Tehran's preconditions threatened to stall formal ceasefire negotiations.
  • Talks aim to secure reopening of the Strait of Hormuz after closures removed roughly 15% of global oil supply, heightening energy-market risk.
  • Bitcoin neared $73,000 as institutional ETF demand and forced bearish liquidations drove gains across crypto markets.
  • Japan pledged an extra ¥631.5 billion for Rapidus R&D to accelerate domestic 2nm chip production and bolster semiconductor supply chains.
  • Sources say Iran's new supreme leader is recovering from major injuries, raising doubts about his capacity to exercise full authority.

Latest Articles

Hotel101 Global Holdings Corp. Takes Next Step for Proposed US$300 Million Series A Perpetual Preferred Share Offering

Hotel101 Global Holdings Corp. Takes Next Step for Proposed US$300 Million Series A Perpetual Preferred Share Offering

Hotel101 Global Holdings Corp. announced a planned extraordinary general meeting of shareholders to approve amendments allowing issuance of up to $300 million in Series A Preferred Shares as part of its capital raising strategy. The company aims to boost strategic initiatives for expanding its hospitality footprint to 25 countries medium term, targ…

YXT.com Reports Full Year 2025 Unaudited Financial Results

YXT.com Reports Full Year 2025 Unaudited Financial Results

YXT.com Group Holding Limited reported its unaudited financial results for the full year ended December 31, 2025, revealing a 2.7% increase in total revenues to RMB340.2 million (US$48.7 million), and a significant improvement in gross margin to 68.3% driven by cost efficiencies and strategic focus on AI-enhanced corporate learning solutions. Despi…

Bitfarms Reports Fiscal Year 2025 Results

Bitfarms Reports Fiscal Year 2025 Results

Bitfarms Ltd. reported strong fiscal year 2025 results, showcasing significant revenue growth and advancement in its strategic pivot from Bitcoin mining to high-performance computing (HPC) infrastructure focused on AI workloads. The company secured shareholder approval to redomicile from Canada to the U.S. and rebrand as Keel Infrastructure, markin…

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

Biogen is acquiring Apellis Pharmaceuticals for approximately $5.6 billion in cash plus contingent value rights, gaining two FDA-approved immunology and rare disease medicines, EMPAVELI and SYFOVRE. The acquisition is expected to enhance Biogen's growth prospects by adding immediate revenues of $689 million in 2025 from Apellis' products, accelerat…

La Rosa Holdings Adds Over $6.4 Million in Net Assets to Balance Sheet as Part of Digital Asset Treasury to Scale AI Infrastructure Strategy

La Rosa Holdings Adds Over $6.4 Million in Net Assets to Balance Sheet as Part of Digital Asset Treasury to Scale AI Infrastructure Strategy

La Rosa Holdings Corp. announced the addition of $6.4 million in net assets from its digital asset treasury strategy to enhance liquidity for expanding its AI infrastructure and real estate portfolio. The Company plans to acquire land in Osceola County, Florida, for a Tier III AI data center and intends to acquire Consensus Core Technologies, a pro…

AH Realty Trust Advances Strategic Transformation Through Sale of Two Multifamily Real Estate Financing Investments

AH Realty Trust Advances Strategic Transformation Through Sale of Two Multifamily Real Estate Financing Investments

AH Realty Trust has sold two multifamily notes for $63 million as part of its strategic exit from real estate financing, aiming to simplify its platform and focus on core retail and office assets. The company plans to use proceeds to pay down debt and support its share repurchase program, having already repurchased approximately 3.6 million shares …

T1 Energy Reports Fourth Quarter and Full-Year 2025 Results

T1 Energy Reports Fourth Quarter and Full-Year 2025 Results

T1 Energy Inc. (NYSE: TE) announced its fourth quarter and full-year 2025 financial results, highlighting significant progress in the construction of its G2_Austin 2.1 GW solar cell fab, on track for Q4 2026 production start. The company achieved record quarterly module production and sales at its G1_Dallas facility in Q4 2025, expanded utility-sca…

AGA Precision Systems Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products

AGA Precision Systems Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products

AGA Precision Systems, a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB), has signed a long-term agreement to supply mission-critical aerospace and defense components to Turbo-Jet Products. The agreement spans an initial five years with options for renewal, reinforcing AGA's strategic role in the aerospace and defense supply chain, supported by its…

MiNK Therapeutics Reports Q4 and Full Year 2025 Results; Phase 2 Programs Advance with Impactful Non-Dilutive Momentum

MiNK Therapeutics Reports Q4 and Full Year 2025 Results; Phase 2 Programs Advance with Impactful Non-Dilutive Momentum

MiNK Therapeutics reported their Q4 and full-year 2025 financial results, highlighting significant progress in their iNKT cell therapy pipeline targeting severe immune-mediated diseases such as ARDS, pulmonary fibrosis, cancer, and GVHD. The company secured non-dilutive funding from collaborations and grants, advanced multiple clinical programs, an…